An Evaluation Of The Novel TRAMINER Sequence By Comparison To Late Gadolinium Enhancement Images
NCT ID: NCT02727725
Last Updated: 2024-10-04
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
100 participants
INTERVENTIONAL
2016-01-15
2018-01-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
* The hypothesis is that the TRAMINER sequence has the same or higher sensitivity in detecting small sub-endocardial scarring than the inversion recovery segmented gradient echo sequence known as IR-Turbo Fast low angle shot (IR Turbo-Flash), which is the accepted current gold standard for the detection of myocardial viability.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Intracoronary Thrombus Detection by Magnetic Resonance Imaging
NCT02776657
Technical Development of Cardiovascular Magnetic Resonance Imaging
NCT00027170
Detection and Significance of Heart Injury in ST Elevation Myocardial Infarction.
NCT02072850
Whole Body Magnetic Resonance Angiography in Ischemic Patients at 1.5 and 3T
NCT00554073
Clinical Implication CMR in AMI Registry
NCT04788940
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
DIAGNOSTIC
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Traminer MRI Sequence
The TRAMINER MRI sequence implementation to be tested allows the acquisition of high resolution MR images in the free-breathing patient, by combining multiple averages and motion correction with the TRAMINER preparation.
Traminer MRI Sequence
The Traminer MRI sequence will be added to the standard IR Turbo-Flash sequence and last 2-5 minutes.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Traminer MRI Sequence
The Traminer MRI sequence will be added to the standard IR Turbo-Flash sequence and last 2-5 minutes.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Adults unable to consent
* Adults for whom the MRI has not been previously scheduled
* Adults with an order for any MRI other than cardiac MRI with Gadolinium enhancement
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Siemens Corporation, Corporate Technology
INDUSTRY
Wake Forest University Health Sciences
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Nayla Chaptini, MD
Role: PRINCIPAL_INVESTIGATOR
Advocate Lutheran General Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Advocate Lutheran General Hospital
Park Ridge, Illinois, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
AHC IRB 5886
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.